Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Etna Biotech

Etna Biotech?uq=gJQ7UQwH
2001 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of vaccines. The company's key competencies lie in researching and developing vaccines and immunotherapeutics for infectious diseases and other chronic illnesses. Its pipeline includes vaccines for Hepatitis A, Congo fever, HPV, influenza, malaria, typhoid and Varicella, among others.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Parent Company
Primary Office
  • Via Vincenzo Lancia, 57
  • Zona Industriale Blocco Palma 1
  • 95121 Catania
  • Italy

+39 095 000 0000

Etna Biotech Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Etna Biotech‘s full profile, request access.

Request full access to PitchBook

Etna Biotech Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Etna Biotech‘s full profile, request access.

Request full access to PitchBook

Etna Biotech Executive Team (1)

Name Title Board
Seat
Contact
Info
Reinhard Glueck Chairman & Chief Executive Officer

Etna Biotech Board Members (1)

Name Representing Role Since Contact
Info
00000000 000000 Etna Biotech Chairman & Chief Executive Officer 000 0000